EP0735893 - PAN DR-BINDING PEPTIDES FOR ENHANCEMENT OF THE IMMUNE RESPONSE [Right-click to bookmark this link] | |||
Former [1996/41] | ALTERATION OF IMMUNE RESPONSE USING PAN DR-BINDING PEPTIDES | ||
[2006/40] | Status | No opposition filed within time limit Status updated on 02.10.2009 Database last updated on 28.06.2024 | Most recent event Tooltip | 02.10.2009 | No opposition filed within time limit | published on 04.11.2009 [2009/45] | Applicant(s) | For all designated states Pharmexa Inc. 5820 Nancy Ridge Drive, Suite 100 San Diego, CA 92121 / US | [2006/43] |
Former [1999/24] | For all designated states Epimmune Inc. 6555 Nancy Ridge Drive, Suite 200 San Diego, California 92121 / US | ||
Former [1998/32] | For all designated states Epimmune, Inc. 6555 Nancy Ridge Drive, Suite 200 San Diego, California 92121 / US | ||
Former [1996/41] | For all designated states CYTEL CORPORATION 3525 John Hopkins Court San Diego, CA 92121 / US | Inventor(s) | 01 /
SETTE, Alessandro 5531 Beaumont Avenue La Jolla, CA 92037 / US | 02 /
GAETA, Federico C.A. 3226 Rim Rock Circle Olivenhain, CA 92024 / US | 03 /
GREY, Howard M. 8307 Caminito Helecho La Jolla, CA 92037 / US | 04 /
SIDNEY, John 8541-D Villa La Jolla Drive La Jolla, CA 92037 / US | 05 /
ALEXANDER, Jerrery L. 117 Mangano Circle Encinitas, CA 92024 / US | [1996/41] | Representative(s) | Armitage, Ian Michael, et al Mewburn Ellis LLP York House 23 Kingsway London WC2B 6HP / GB | [N/P] |
Former [1996/41] | Armitage, Ian Michael, et al MEWBURN ELLIS York House 23 Kingsway London WC2B 6HP / GB | Application number, filing date | 94929801.2 | 14.09.1994 | [1996/41] | WO1994US10368 | Priority number, date | US19930121101 | 14.09.1993 Original published format: US 121101 | [1996/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9507707 | Date: | 23.03.1995 | Language: | EN | [1995/13] | Type: | A1 Application with search report | No.: | EP0735893 | Date: | 09.10.1996 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.03.1995 takes the place of the publication of the European patent application. | [1996/41] | Type: | B1 Patent specification | No.: | EP0735893 | Date: | 26.11.2008 | Language: | EN | [2008/48] | Search report(s) | International search report - published on: | US | 23.03.1995 | (Supplementary) European search report - dispatched on: | EP | 18.12.1997 | Classification | IPC: | A61K39/39, A61K38/00, C07K1/00, C07K5/00, C07K7/00, C07K14/00, C07K17/00 | [2006/40] | CPC: |
C07K7/08 (EP,US);
A61P37/00 (EP);
A61P37/04 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
C07K14/001 (EP,US);
C07K14/005 (EP,US);
C07K14/70539 (EP,US);
A61K38/00 (EP,US);
|
Former IPC [1996/41] | A61K38/00, C07K1/00, C07K5/00, C07K7/00, C07K14/00, C07K17/00 | Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1996/41] | Title | German: | PAN DR-BINDEPROTEINEN ZUR ERHÖHUNG DER IMMUNANTWORT | [2006/40] | English: | PAN DR-BINDING PEPTIDES FOR ENHANCEMENT OF THE IMMUNE RESPONSE | [2006/40] | French: | PEPTIDES SE LIANT A DES ALLELES PAN DR POUR L'AUGMENTATION DE LA REPONSE IMMUNITAIRE | [2006/40] |
Former [1996/41] | VERÄNDERUNG DER IMMUNANTWORT DURCH VERWENDUNG VON PAN DR-BINDEPROTEINEN | ||
Former [1996/41] | ALTERATION OF IMMUNE RESPONSE USING PAN DR-BINDING PEPTIDES | ||
Former [1996/41] | ALTERATION DE LA REPONSE IMMUNITAIRE A L'AIDE DE PEPTIDES SE LIANT A DES ALLELES PAN DR | Entry into regional phase | 04.04.1996 | National basic fee paid | 04.04.1996 | Search fee paid | 04.04.1996 | Designation fee(s) paid | 04.04.1996 | Examination fee paid | Examination procedure | 22.03.1995 | Request for preliminary examination filed International Preliminary Examining Authority: US | 04.04.1996 | Examination requested [1996/41] | 03.11.1999 | Despatch of a communication from the examining division (Time limit: M06) | 12.05.2000 | Reply to a communication from the examining division | 25.03.2002 | Despatch of a communication from the examining division (Time limit: M06) | 09.09.2002 | Reply to a communication from the examining division | 07.01.2004 | Despatch of a communication from the examining division (Time limit: M06) | 19.07.2004 | Reply to a communication from the examining division | 19.09.2006 | Date of oral proceedings | 29.09.2006 | Despatch of a communication from the examining division (Time limit: M02) | 29.09.2006 | Minutes of oral proceedings despatched | 04.12.2006 | Reply to a communication from the examining division | 30.03.2007 | Despatch of a communication from the examining division (Time limit: M04) | 19.07.2007 | Reply to a communication from the examining division | 21.08.2007 | Communication of intention to grant the patent | 11.02.2008 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 16.04.2008 | Fee for grant paid | 16.04.2008 | Fee for publishing/printing paid | Divisional application(s) | EP08169874.8 Application deemed to be withdrawn : 26.02.2009 | Opposition(s) | 27.08.2009 | No opposition filed within time limit [2009/45] | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 16.04.2008 | Request for further processing filed | 16.04.2008 | Full payment received (date of receipt of payment) Request granted | 10.06.2008 | Decision despatched | Fees paid | Renewal fee | 19.08.1996 | Renewal fee patent year 03 | 22.08.1997 | Renewal fee patent year 04 | 18.11.1998 | Renewal fee patent year 05 | 23.08.1999 | Renewal fee patent year 06 | 28.08.2000 | Renewal fee patent year 07 | 24.09.2001 | Renewal fee patent year 08 | 23.09.2002 | Renewal fee patent year 09 | 24.09.2003 | Renewal fee patent year 10 | 23.09.2004 | Renewal fee patent year 11 | 21.09.2005 | Renewal fee patent year 12 | 27.09.2006 | Renewal fee patent year 13 | 26.09.2007 | Renewal fee patent year 14 | 25.09.2008 | Renewal fee patent year 15 | Penalty fee | Additional fee for renewal fee | 30.09.1998 | 05   M06   Fee paid on   18.11.1998 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9202543 (CYTEL CORP [US], et al) [X] 1-4,11-17 * page 8, paragraph L * * page 10, paragraph L - page 12 * * page 5 - page 6 * * page 15, paragraph 2 * * page 26; claims 1,2,7,8,13 *; | [XY]WO9305011 (SANDOZ LTD [CH], et al) [X] 1-4,11-17 * page 57, paragraph L; claims 1-3; table 1 * [Y] 5-10; | [Y]EP0534615 (CYTEL CORP [US]) [Y] 5-10 * claims 7,11,13,20 * * page 3, line 23 - line 29 * * page 9, line 39 - page 10, line 7 *; | [X] - M.F. POWELL, "Peptide stability in drug development", PHARM. RES., (199309), vol. 10, no. 9, pages 1268 - 1273, XP000569558 [X] 1-4,11-17 * page 1272, column 1; figures 1,5 * DOI: http://dx.doi.org/10.1023/A:1018953309913 | [A] - D. O'SULLIVAN ET AL, "On the interaction of promiscuous antigenic peptides with different DR alleles", J. IMMUNOLOGY, (199110), vol. 147, no. 8, pages 2663 - 2669, XP002046346 [A] * page 2669, column 1 * | [A] - J.H. BROWN ET AL, "Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1", NATURE, (199307), vol. 364, pages 33 - 39, XP002046347 [A] * the whole document * DOI: http://dx.doi.org/10.1038/364033a0 | [T] - J. ALEXANDER ET AL, "Development of High potency universal DR-Restricted Helper Epitopes by modification of high affinity DR-blocking peptides", IMMUNITY, (199412), vol. 1, pages 751 - 761, XP000673954 DOI: http://dx.doi.org/10.1016/S1074-7613(94)80017-0 | International search | [Y]US5114713 (SINIGAGLIA FRANCESCO [CH]); | [Y]US5196512 (BIANCHI ELISABETTA [US], et al); | [YP]US5336758 (BERZOFSKY JAY A [US], et al) |